Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

A Pilot Multi-Pronged Approach to Measuring Endothelial Dysfunction and Predict the Development of Endothelial Disorders and Death Post Hematopoietic Cell Transplantation (HCT)

Michelle L Schoettler, Ritu Sachdeva, Muna Qayed, Benjamin Watkins, Suhag Parikh, Kathryn Leung, Elizabeth O Stenger, Ann Haight, Katherine Silvis, Yvonne Suessmuth, Adrianna Westbrook, Kirsten M. Williams

Blood (2024) 144 (Supplement 1): 4888.

https://doi.org/10.1182/blood-2024-208492

Published: 2024

Journal Articles

Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

Staci D. Arnold, Nitya Bakshi, Zhao Chang, Diana Ross, Allistair Abraham, Monica Bhatia, Gregory M.T. Guilcher, Ann Haight, Matthew Hsieh, Kimberly A. Kasow, Peter A. Lane, Lillian Meacham, Festus Olusola Olowoselu, Lakshmanan Krishnamurti

Blood (2021) 138 (Supplement 1): 425.

https://doi.org/10.1182/blood-2021-154280

Published: 2021

Journal Articles

Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium (PTCTC)

Blood (2020) 136 (Supplement 1): 42–43.

https://doi.org/10.1182/blood-2020-139958

Published: 2020

Journal Articles

HLA Class I Alloimmunization and Platelet Transfusion Support in HLA-Identical Bone Marrow Transplant for Sickle Cell Disease: A Sickle Transplant Alliance for Research Study

Robert Sheppard Nickel, MD MSc, John T. Horan, MD MPH, Allistair Abraham, MD, Muna Qayed, MD MSc, Ann Haight, MD, Naomi Luban, MD, Jeanne E. Hendrickson, MD

Blood (2018) 132 (Supplement 1): 3816.

https://doi.org/10.1182/blood-2018-99-114116

Published: 2018

Journal Articles

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

Elizabeth Stenger, MD, Kirshma Khemani, MD, Diana Ross, MSN, RN, Lillian Meacham, MD, Courtney McCracken, PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD

Blood (2017) 130 (Supplement 1): 1999.

https://doi.org/10.1182/blood.V130.Suppl_1.1999.1999

Published: 2017

Journal Articles

CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation

Hirozumi Sano, MD, Joseph Hilinski, MD, Kristy Applegate, MBA, Andres Camacho-Gonzalez, MD, Shanmuganathan Chandrakasan, MD, Kuang-Yueh Chiang, MD PhD, Ann Haight, MD, Lakshmanan Krishnamurti, MD, Elizabeth Stenger, MD, Muna Qayed, MD MSc, John Horan, MD MPH

Blood (2016) 128 (22): 3397.

https://doi.org/10.1182/blood.V128.22.3397.3397

Published: 2016

Journal Articles

Experiences and Decision Making for Bone Marrow Transplant in Sickle Cell Disease: Patients and Caregivers Perspective

Kirshma Khemani, MD, Diana Ross, MSN, RN, Ann Haight, MD, Cynthia Sinha, PhD, Nitya Bakshi, MBBS, MS, Lakshmanan Krishnamurti, MD

Blood (2016) 128 (22): 2393.

https://doi.org/10.1182/blood.V128.22.2393.2393

Published: 2016

Journal Articles

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

Blood (2013) 122 (21): 543.

https://doi.org/10.1182/blood.V122.21.543.543

Published: 2013

Journal Articles

Older Patients with Hodgkin Lymphoma (HL) Undergoing Autologous Stem Cell Transplantation for Relapsed/Refractory Disease Have Inferior Survival Compared to Younger Patients

Akshay Sharma, MD, Minghui Duan, MD, Michael Graiser, PhD, Hongzheng Zhang, MPH PhD, Amelia Langston, MD, Sagar Lonial, MD, Christopher R Flowers, MD, Ann Haight, MD, Edmund K Waller, MD PhD

Blood (2011) 118 (21): 4521.

https://doi.org/10.1182/blood.V118.21.4521.4521

Published: 2011

Journal Articles

Relationship of Targeted Busulfan Exposure to Engraftment in Children Undergoing Myeloablative Matched Sibling Donor Transplantation for Sickle Cell Disease.

Marianne E. McPherson, MD, Don Hutcherson, RPh, Ellen Olson, CPNP, Ann Haight, MD, John Horan, MD, MPH, Kuang-Yueh Chiang, MD, PhD

Blood (2008) 112 (11): 2152.

https://doi.org/10.1182/blood.V112.11.2152.2152

Published: 2008

Journal Articles

Successful Engraftment Using Varied Stem Cell Sources, Low Toxicity, and Long-Term Survival Using a Bu/Flu/ATG Reduced Intensity Allogeneic Transplantation in High Risk Pediatric Patients Ineligible for Myelablative Therapy: Results of the Pediatric Blood and Marrow Transplant Consortium (PBMTC) Study ONC0313.

Michael A. Pulsipher, Haydar Frangoul, Michel Duval, Rakesh Goyal, Peter J. Shaw, Ann Haight, Richard Kadota, Michael Grimley, Stephan A. Grupp, Morris Kletzel

Blood (2007) 110 (11): 623.

https://doi.org/10.1182/blood.V110.11.623.623

Published: 2007

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) in Children with Sickle Cell Disease (SCD): US Centers Experience.

Tom V. Adamkiewicz, MD, Ann Haight, MD, Melissa A. Mazur, MD, K. Scott Baker, MD, Paul Szabolcs, MD, Amos Kedar, MD, K.Y. Chiang, MD, Lakshmanan Krishnamurti, MD, John E. Wagner, MD, John R. Wingard, MD, Andrew M. Yeager, MD

Blood (2005) 106 (11): 2044.

https://doi.org/10.1182/blood.V106.11.2044.2044

Published: 2005

NARROW

A Pilot Multi-Pronged Approach to Measuring Endothelial Dysfunction and Predict the Development of Endothelial Disorders and Death Post Hematopoietic Cell Transplantation (HCT)

Long-Term Quality of Life after Hematopoietic Cell Transplantation for Sickle Cell Disease: A Preliminary Report from the Sickle Cell Transplant Evaluation of Long Term and Late Effects Registry (STELLAR)

Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium (PTCTC)

HLA Class I Alloimmunization and Platelet Transfusion Support in HLA-Identical Bone Marrow Transplant for Sickle Cell Disease: A Sickle Transplant Alliance for Research Study

Increased Proportion of Sickle Cell Disease Patients Develop Cardiovascular Disease Risk Factors Following Successful Hematopoietic Cell Transplantation

CMV Viremia and African-American Ethnicity Are Risk Factors for Post-Engraftment Blood Stream Infections in Pediatric Allogeneic Blood and Marrow Transplantation

Experiences and Decision Making for Bone Marrow Transplant in Sickle Cell Disease: Patients and Caregivers Perspective

Multicenter Investigation Of Unrelated Donor Hematopoietic Cell Transplantation (HCT) For Thalassemia Major After a Reduced Intensity Conditioning Regimen (URTH Trial)

Older Patients with Hodgkin Lymphoma (HL) Undergoing Autologous Stem Cell Transplantation for Relapsed/Refractory Disease Have Inferior Survival Compared to Younger Patients

Relationship of Targeted Busulfan Exposure to Engraftment in Children Undergoing Myeloablative Matched Sibling Donor Transplantation for Sickle Cell Disease.

Unrelated Cord Blood Transplantation (UCBT) in Children with Sickle Cell Disease (SCD): US Centers Experience.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only